1 year return (CAGR)
1741.06%
Quince Therapeutics, Inc. Exchange (NASDAQ, USD)
QNCX
32.95
+0.48 (+1.48%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
220.61%
5 year return (CAGR)
-10.70%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
33.52M
Price/Sales
-
Ent value
-66.96M
Price/Book
0.31
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
44.79%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 32.32 |
| Daily high | 33.40 |
| Daily low | 31.00 |
| Daily Volume | 63K |
| All-time high | 120.21 |
| 1y analyst estimate | 75.43 |
| Beta | 1.31 |
| EPS (TTM) | -15.08 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| QNCX | S&P500 | |
| Current price drop from All-time high | -72.59% | -0.87% |
| Highest price drop | -99.89% | -56.47% |
| Date of highest drop | 9 Feb 2026 | 9 Mar 2009 |
| Avg drop from high | -76.07% | -10.65% |
| Avg time to new high | 82 days | 12 days |
| Max time to new high | 1311 days | 1805 days |
News
No items found